Solborn Inc (035610) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Solborn Inc (035610) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-8.53 Billion ≈ $-5.78 Million USD) by net assets (₩320.91 Billion ≈ $217.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Solborn Inc's balance sheet to measure how much of total assets are equity-financed.
Solborn Inc - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Solborn Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 035610 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Solborn Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solborn Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
-0.070x |
|
Thai Plaspac Public Company Limited
BK:TPAC
|
0.071x |
|
Peninsula Energy Ltd
AU:PEN
|
-0.085x |
|
Veracruz Properties SOCIMI SA
MC:YVCP
|
0.025x |
|
Talga Group Ltd
F:TGX
|
-0.234x |
|
AXON PARTNERS GRP EO -10
F:XE1
|
N/A |
|
MEDIPOST Co. Ltd
KQ:078160
|
-0.054x |
|
Shotspotter Inc
NASDAQ:SSTI
|
0.062x |
Annual Cash Flow Conversion Efficiency for Solborn Inc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Solborn Inc from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Solborn Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩206.50 Billion ≈ $139.94 Million |
₩15.31 Billion ≈ $10.37 Million |
0.074x | +8.85% |
| 2023-12-31 | ₩164.74 Billion ≈ $111.64 Million |
₩11.22 Billion ≈ $7.60 Million |
0.068x | -43.17% |
| 2022-12-31 | ₩123.84 Billion ≈ $83.92 Million |
₩14.84 Billion ≈ $10.05 Million |
0.120x | +22.33% |
| 2021-12-31 | ₩161.60 Billion ≈ $109.51 Million |
₩15.83 Billion ≈ $10.73 Million |
0.098x | -23.56% |
| 2020-12-31 | ₩138.68 Billion ≈ $93.98 Million |
₩17.77 Billion ≈ $12.04 Million |
0.128x | +31.52% |
| 2019-12-31 | ₩140.28 Billion ≈ $95.07 Million |
₩13.67 Billion ≈ $9.26 Million |
0.097x | +136.95% |
| 2018-12-31 | ₩138.76 Billion ≈ $94.04 Million |
₩5.71 Billion ≈ $3.87 Million |
0.041x | +36.20% |
| 2017-12-31 | ₩127.51 Billion ≈ $86.41 Million |
₩3.85 Billion ≈ $2.61 Million |
0.030x | +192.13% |
| 2016-12-31 | ₩128.86 Billion ≈ $87.32 Million |
₩1.33 Billion ≈ $902.41K |
0.010x | -80.99% |
| 2015-12-31 | ₩128.76 Billion ≈ $87.26 Million |
₩7.00 Billion ≈ $4.74 Million |
0.054x | +492.09% |
| 2014-12-31 | ₩155.41 Billion ≈ $105.32 Million |
₩1.43 Billion ≈ $966.70K |
0.009x | -90.69% |
| 2013-12-31 | ₩152.09 Billion ≈ $103.07 Million |
₩14.99 Billion ≈ $10.16 Million |
0.099x | +162.07% |
| 2012-12-31 | ₩144.67 Billion ≈ $98.04 Million |
₩5.44 Billion ≈ $3.69 Million |
0.038x | -13.47% |
| 2011-12-31 | ₩148.02 Billion ≈ $100.31 Million |
₩6.43 Billion ≈ $4.36 Million |
0.043x | -17.20% |
| 2009-12-31 | ₩139.04 Billion ≈ $94.23 Million |
₩7.30 Billion ≈ $4.95 Million |
0.053x | -1.93% |
| 2008-12-31 | ₩131.24 Billion ≈ $88.94 Million |
₩7.03 Billion ≈ $4.76 Million |
0.054x | +3762.94% |
| 2007-12-31 | ₩143.25 Billion ≈ $97.08 Million |
₩198.51 Million ≈ $134.53K |
0.001x | -97.35% |
| 2006-12-31 | ₩171.26 Billion ≈ $116.06 Million |
₩8.96 Billion ≈ $6.07 Million |
0.052x | +158.94% |
| 2004-12-31 | ₩203.13 Billion ≈ $137.66 Million |
₩4.10 Billion ≈ $2.78 Million |
0.020x | -- |
About Solborn Inc
Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services. In addition, the company invests in small and me… Read more